Figure 1From: Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDsUnderutilization of preventive strategies in patients receiving NSAIDs. (a) Patients with one risk factor for upper gastrointestinal ulcer complications. (b) Patients with two or more risk factors for upper gastrointestinal ulcer complications. Percentages total more than 100% because of rounding. COX, cyclo-oxygenase; GPA, gastroprotective agent; NSAID, nonsteroidal anti-inflammatory drug. Reproduced with permission from Oxford University Press [2].Back to article page